| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAUCGAGGGUUUCGGGGACGCCGAGCGGCACUUUCCUCUUCCCAGCGAG… | 6336 nt | 0.4306 | |
| UCUUUAAGAUUUGUAGCUACUAAGAAAGAAAGGAGCUUUUUUUCCUUGG… | 6308 nt | 0.4199 | |
| AAUCGAGGGUUUCGGGGACGCCGAGCGGCACUUUCCUCUUCCCAGCGAG… | 6339 nt | 0.4307 |
This locus encodes the transforming growth factor (TGF)-beta type III receptor. The encoded receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.[provided by RefSeq, Sep 2010] CIViC Summary for TGFBR3 Gene
A study in mice and rats demonstrated that the TGFBR3 is a target of miR-223-3p and miR-147-5p, with its expression being negatively correlated with miR-223-3p in myocardial infarction models [Tuerxun et al. DOI:10.1007/s12013-024-01528-x]. In human sepsis patients, the TGFBR3 was identified as a core prognostic gene, with its expression significantly down-regulated in peripheral blood and associated with positive 28-day survival, and it is part of a constructed ceRNA regulatory network involving specific miRNAs and lncRNAs [Zhang et al. DOI:10.1186/s12920-023-01460-8]. In a rat model of polytrauma, local mRNA expression of the TGFBR3 was significantly downregulated at the fracture site at 10 days post-trauma compared to osteotomy alone [Mangum et al. DOI:10.1186/s13018-019-1082-4].